Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Alzheimers Dement. 2020 May 20;16(7):953–964. doi: 10.1002/alz.12090

Table 3.

Standardized incidence rate ratios (SIRs) with 95% confidence intervals (CIs) and absolute reduction in dementia risk attributed to cancer per 10,000 person-years for any dementia, in 679,122 Danish cancer patients with specific cancer sites diagnosed between 1980 and 2013, by stage.

Alzheimer’s disease Vascular dementia All-cause dementia

Observed number Expected number SIR (95% CI) Absolute risk reduction Observed number Expected number SIR (95% CI) Absolute risk reduction Observed number Expected number SIR (95% CI) Absolute risk reduction

Bladder cancer 227 242 0.94 (0.82, 1.07) 1.6 98 97 1.01 (0.82, 1.23) −0.1 640 662 0.97 (0.89, 1.04) 2.3
Localized 135 148 0.91 (0.77, 1.08) 2.1 59 60 0.99 (0.75, 1.28) 0.1 385 403 0.96 (0.86, 1.06) 3.0
Regional 28 23 1.23 (0.81, 1.77) −5.2 17 9 1.90 (1.11, 3.05) −8.1 67 60 1.11 (0.86, 1.41) −6.8
Distant <5 3 NA 12.9 <5 1 NA 7.6 8 7 1.08 (0.47, 2.13) −3.9
Missing/Unknown 63 69 0.92 (0.70, 1.17) 2.5 22 28 0.79 (0.50, 1.20) 2.5 180 192 0.94 (0.81, 1.09) 5.0

Brain cancer 13 8 1.62 (0.86, 2.77) −1.6 10 3 2.90 (1.39, 5.33) −2.1 91 24 3.77 (3.03, 4.63) −21.1

Breast cancer 1495 1569 0.95 (0.91, 1.00) 0.8 486 492 0.99 (0.90, 1.08) 0.1 4129 4132 1.00 (0.97, 1.03) 0.0
Localized 899 901 1.00 (0.93, 1.07) 0.0 276 285 0.97 (0.86, 1.09) 0.2 2403 2385 1.01 (0.97, 1.05) −0.4
Regional 419 471 0.89 (0.81, 0.98) 1.7 148 147 1.01 (0.85, 1.18) 0.0 1176 1214 0.97 (0.91, 1.03) 1.2
Distant 30 38 0.79 (0.53, 1.12) 4.3 10 11 0.90 (0.43, 1.66) 0.6 94 95 0.99 (0.80, 1.21) 0.4
Missing/unknown 147 158 0.93 (0.78, 1.09) 1.9 52 50 1.05 (0.78, 1.37) −0.4 456 438 1.04 (0.95, 1.14) −3.0

Colon cancer 833 944 0.88 (0.82, 0.94) 3.6 279 337 0.83 (0.73, 0.93) 1.9 2343 2598 0.90 (0.87, 0.94) 8.4
Localized 207 253 0.82 (0.71, 0.94) 6.0 71 86 0.83 (0.64, 1.04) 1.9 585 668 0.88 (0.81, 0.95) 10.8
Regional 93 104 0.90 (0.73, 1.10) 3.0 22 34 0.64 (0.40, 0.98) 3.4 231 266 0.87 (0.76, 0.99) 9.9
Distant 20 27 0.75 (0.46, 1.16) 5.8 <5 8 NA 4.8 54 64 0.85 (0.64, 1.11) 8.3
Missing/unknown 513 561 0.91 (0.84, 1.00) 2.6 183 208 0.88 (0.76, 1.02) 1.4 1473 1601 0.92 (0.87, 0.97) 7.0

Kidney cancer 86 110 0.78 (0.62, 0.96) 3.7 53 42 1.25 (0.94, 1.63) −1.6 286 303 0.95 (0.84, 1.06) 2.5
Localized 62 74 0.84 (0.65, 1.08) 2.6 43 29 1.48 (1.07, 2.00) −3.1 204 206 0.99 (0.86, 1.14) 0.4
Regional 5 9 0.56 (0.18, 1.30) 8.1 <5 3 NA NA 17 24 0.72 (0.42, 1.15) 13.4
Distant 6 7 0.86 (0.31, 1.86) 2.0 <5 3 NA NA 16 18 0.88 (0.50, 1.43) 4.2
Missing/unknown 13 21 0.63 (0.33, 1.08) 7.6 8 8 1.06 (0.46, 2.08) −0.4 49 55 0.89 (0.66, 1.18) 6.0

Leukemia 150 162 0.93 (0.78, 1.09) 1.2 51 60 0.85 (0.63, 1.11) 0.9 395 440 0.90 (0.81, 0.99) 4.5

Lung cancer 174 207 0.84 (0.72, 0.97) 2.5 65 81 0.80 (0.62, 1.02) 1.2 613 546 1.12 (1.04, 1.22) −5.1
Localized 83 101 0.82 (0.66, 1.02) 2.9 38 41 0.93 (0.66, 1.28) 0.5 291 272 1.07 (0.95, 1.20) −3.0
Regional 32 43 0.75 (0.51, 1.06) 3.2 12 18 0.68 (0.35, 1.19) 1.7 124 115 1.07 (0.89, 1.28) −2.6
Distant 25 38 0.67 (0.43, 0.98) 5.4 8 14 0.58 (0.25, 1.14) 2.5 110 97 1.14 (0.93, 1.37) −5.6
Missing/unknown 34 26 1.31 (0.91, 1.83) −6.5 7 9 0.82 (0.33, 1.68) 1.3 88 61 1.43 (1.15, 1.76) −21.6

Melanoma skin cancer 284 325 0.87 (0.78, 0.98) 1.5 92 124 0.74 (0.60, 0.91) 1.2 805 929 0.87 (0.81, 0.93) 4.5
Localized 253 285 0.89 (0.78, 1.00) 1.3 82 110 0.75 (0.59, 0.93) 1.1 715 820 0.87 (0.81, 0.94) 4.2
Regional 9 10 0.94 (0.43, 1.78) 0.7 <5 4 NA NA 27 27 1.01 (0.66, 1.47) −0.3
Distant <5 2.8 NA NA <5 1 NA NA <5 7 NA NA
Missing/unknown 20 27 0.73 (0.44, 1.12) 3.9 9 10 0.91 (0.42, 1.74) 0.4 59 76 0.78 (0.59, 1.00) 8.9

Non-melanoma skin cancer 3876 4005 0.97 (0.94, 1.00) 0.8 1366 1505 0.91 (0.86, 0.96) 0.9 10805 11479 0.94 (0.92, 0.96) 4.3
Localized 3316 3384 0.98 (0.95, 1.01) 0.5 1171 1277 0.92 (0.87, 0.97) 0.8 9251 9725 0.95 (0.93, 0.97) 3.6
Regional 16 11 1.50 (0.86, 2.43) −15.3 <5 4 NA NA 36 31 1.17 (0.82, 1.63) −15.3
Distant 5 2 2.48 (0.80, 5.77) −35.6 <5 1 NA NA 9 6 1.60 (0.74, 3.05) −40.5
Missing/unknown 539 608 0.89 (0.81, 0.96) 2.8 190 223 0.85 (0.74, 0.98) 1.3 1509 1718 0.88 (0.83, 0.92) 8.5

Pancreatic cancer 19 26 0.72 (0.43, 1.13) 5.2 4 9 0.45 (0.12, 1.15) 3.5 59 66 0.90 (0.69, 1.16) 4.7
Localized 8 7 1.19 (0.51, 2.34) −3.4 <5 2 NA NA 17 17 1.00 (0.58, 1.60) 0.1
Regional <5 6 NA NA <5 2 NA NA 10 14 0.70 (0.34, 1.29) 10.8
Distant <5 5 NA NA <5 2 NA NA 14 11 1.22 (0.67, 2.05) −8.3
Missing/unknown 6 9 0.67 (0.25, 1.46) 9.0 2 3 0.66 (0.08, 2.39) 3.2 18 23 0.79 (0.47, 1.25) 14.9

Prostate cancer 779 813 0.96 (0.89, 1.03) 1.2 325 340 0.96 (0.85, 1.07) 0.5 2175 2237 0.97 (0.93, 1.01) 2.2
Localized 387 399 0.97 (0.88, 1.07) 0.8 162 164 0.99 (0.84, 1.15) 0.1 1080 1077 1.00 (0.94, 1.06) −0.2
Regional 29 27 1.09 (0.73, 1.57) −2.1 10 11 0.91 (0.43, 1.67) 0.9 69 70 0.98 (0.76, 1.24) 1.2
Distant 84 94 0.90 (0.72, 1.11) 3.1 22 40 0.55 (0.35, 0.83) 5.7 217 258 0.84 (0.73, 0.96) 13.0
Missing/unknown 279 294 0.95 (0.84, 1.07) 1.8 131 125 1.05 (0.88, 1.24) −0.7 809 831 0.97 (0.91, 1.04) 2.5